KRRO - NASDAQ

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%

HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$110.28M

EPS-12.4800

P/E Ratio-0.89

Earnings Date08/11/2026

krro

Free Cash Flow

Last Annual Value

-79.08M

3-Year CAGR

-10%

5-Year CAGR

-9%

10-Year CAGR

-17%

Adjust for Inflation

Korro Bio, Inc. Competitors Analysis of Free Cash Flow

KRRO · NASDAQ

Company	Free Cash Flow	CAGR 3Y	CAGR 5Y	CAGR 10Y
Korro Bio, Inc. NASDAQ:KRRO	-79.08M	N/A	N/A	N/A
Alto Neuroscience, Inc. NYSE:ANRO	-51.79M	N/A	N/A	N/A
Aura Biosciences, Inc. NASDAQ:AURA	-85.19M	N/A	N/A	N/A
Larimar Therapeutics, Inc. NASDAQ:LRMR	-113.29M	N/A	N/A	N/A
Altimmune, Inc. NASDAQ:ALT	-67.55M	N/A	N/A	N/A
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	-81.88M	N/A	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	-97.23M	N/A	N/A	N/A
RAPT Therapeutics, Inc. NASDAQ:RAPT	-83.42M	N/A	N/A	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	-190.45M	N/A	N/A	N/A
LB Pharmaceuticals Inc Common Stock NASDAQ:LBRX	-35.26M	N/A	N/A	N/A
Annexon, Inc. NASDAQ:ANNX	-186.49M	N/A	N/A	N/A

Korro Bio, Inc. Fair Value Envelope

KRRO · NASDAQ

Our analysis suggests that KRRO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.08, this represents a potential HIDDEN relative to our calculated worth for Korro Bio, Inc..

HIDDEN

Intrinsic Value

Current Price: $11.08

Related Guides

Blog Categories

Continue your KRRO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.